TC

27/06/2016 16:31

Uni-Bio Group (00690) joins hands with CR Zizhu for Genesoft

    Uni-Bio Science Group (00690) said it entered into a strategic alliance agreementwith China Resources Zizhu Pharmaceutical Co., Ltd., a subsidiary of China Resources Pharmaceutical Group.
  The Uni-Bio Science group granted a sole distribution and promotion rights of Genesoft to CR Zizhu to market and sell Genesoft in China and introduce Genesoft into CR Zizhu's existing domestic hospital network. The agreement has a term of five years, which can be renewed upon expiry but subject to negotiation.
  Genesoft has immediate access to CR Zizhu's network for commercializing the drug, a distribution platform with a proven track record and a seasoned sales and marketing team. Currently, GeneSoft is reimbursed in Jilin and Yunnan provinces as well as Tianjin municipality. The Group believes that through leveraging CR Zizhu's extensive
distribution network and expertise in sales and marketing, distribution of GeneSoft can be expanded to new regions more quickly, thereby driving further business growth.
  Genesoft is an ophthalmic solution containing a derivative of recombinant human epidermal growth factor (rhEGF) which enhances the healing of cornea wounds by promoting corneal epithelium regeneration. 

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【嚴正聲明】《經濟通》呼籲公眾提高警覺留意偽冒《經濟通》投資群組

如何分辨問米是否真實?通靈問事用什麼工具都可以?靈靈法即場示範通靈!

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

貨幣攻略

大國博弈

說說心理話

Watche Trends 2024

北上食買玩

Art Month 2024

理財秘笈

夏天養生食療

消委會報告

山今養生智慧

輕鬆護老